Pfenex Inc. (PFNX)
(Delayed Data from AMEX)
$5.53 USD
+0.06 (1.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $5.53 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$5.53 USD
+0.06 (1.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $5.53 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Are Options Traders Betting on a Big Move in Pfenex (PFNX) Stock?
by Zacks Equity Research
Investors need to pay close attention to Pfenex (PFNX) stock based on the movements in the options market lately.
Earnings Preview: Pfenex (PFNX) Q2 Earnings Expected to Decline
by Zacks Equity Research
Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Pfenex (PFNX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pfenex (PFNX) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Pfenex (PFNX) delivered earnings and revenue surprises of 20.83% and 14.30%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Pfenex (PFNX) Matches Q3 Earnings Estimates
by Zacks Equity Research
Pfenex (PFNX) delivered earnings and revenue surprises of 0.00% and 3.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Pfenex (PFNX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Pfenex (PFNX) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Pfenex (PFNX) stock based on the movements in the options market lately.
Pfenex (PFNX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Pfenex (PFNX) delivered earnings and revenue surprises of 4.00% and -50.25%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Will Pfenex (PFNX) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pfenex Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Pfenex has been struggling lately, but the selling pressure may be coming to an end soon.
Pfenex Inc. (PFNX) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Pfenex Inc. (PFNX).
Pfenex (PFNX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Pfenex (PFNX) delivered earnings and revenue surprises of 52.00% and 84.05%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Pfenex (PFNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Pfenex Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Pfenex.
Pfenex (PFNX) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Pfenex (PFNX) delivered earnings and revenue surprises of 29.03% and -46.64%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Pfenex (PFNX) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Pfenex (PFNX) delivered earnings and revenue surprises of -41.67% and -43.33%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Pfenex (PFNX) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pfenex (PFNX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Pfenex (PFNX) delivered earnings and revenue surprises of -24.24% and -24.51%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
What Downbeat 2018? These 5 Top Stocks Are Up More Than 100%
by Sanghamitra Saha
These five stocks gained more than 100% defying the market sluggishness this year.
Pfenex (PFNX) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Pfenex Inc. (PFNX)
New Strong Sell Stocks for August 28th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: